{"title":"A Case of Hypophosphatasia With Normal Alkaline Phosphatase Levels","authors":"Antara Dattagupta MD, MEng , Steven Petak MD, JD","doi":"10.1016/j.aace.2023.11.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Objective</h3><p>Hypophosphatasia (HPP) is a rare disease associated with low serum alkaline phosphatase (ALP) activity. Here, we present a case of a patient with normal serum ALP levels diagnosed with HPP.</p></div><div><h3>Case Report</h3><p>A 36-year-old woman presented with progressive fatigue, weakness, and joint pain. She had been evaluated in the past for genetic disorders due to these symptoms and was found to have a history of several total ALP levels within normal limits but elevated vitamin B6 levels. She also reported having loose teeth and “gray gums” during her childhood. Bone-specific ALP was tested for suspicion of HPP and returned at 4.4 μ/L (reference range, 5.3-19.5 μg/L), which prompted genetic testing. Genetic testing confirmed a positive pathogenetic variant of the <em>ALPL</em> gene, the c.542C>T (p.Ser181Leu) variant. She started asfotase alfa treatment to improve her symptoms.</p></div><div><h3>Discussion</h3><p>HPP was diagnosed based on clinical suspicion supported by laboratory findings, which can cause it to be underdiagnosed or misdiagnosed. Current literature reports that a low total ALP level is the main biochemical marker of HPP and the only level needed to diagnose the disease. However, bone-specific ALP, a common marker used for bone turnover, has not been required to be tested.</p></div><div><h3>Conclusion</h3><p>This case highlights a patient with normal total ALP, but low bone-specific ALP diagnosed with HPP confirmed by genetic testing. This case warrants future investigation into the diagnostic approach to HPP and the diagnostic utility between ALP and bone-specific ALP.</p></div>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 2","pages":"Pages 38-40"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2376060523001621/pdfft?md5=3c19a6e0bea915174f99472a98e3bfac&pid=1-s2.0-S2376060523001621-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AACE Clinical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2376060523001621","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background/Objective
Hypophosphatasia (HPP) is a rare disease associated with low serum alkaline phosphatase (ALP) activity. Here, we present a case of a patient with normal serum ALP levels diagnosed with HPP.
Case Report
A 36-year-old woman presented with progressive fatigue, weakness, and joint pain. She had been evaluated in the past for genetic disorders due to these symptoms and was found to have a history of several total ALP levels within normal limits but elevated vitamin B6 levels. She also reported having loose teeth and “gray gums” during her childhood. Bone-specific ALP was tested for suspicion of HPP and returned at 4.4 μ/L (reference range, 5.3-19.5 μg/L), which prompted genetic testing. Genetic testing confirmed a positive pathogenetic variant of the ALPL gene, the c.542C>T (p.Ser181Leu) variant. She started asfotase alfa treatment to improve her symptoms.
Discussion
HPP was diagnosed based on clinical suspicion supported by laboratory findings, which can cause it to be underdiagnosed or misdiagnosed. Current literature reports that a low total ALP level is the main biochemical marker of HPP and the only level needed to diagnose the disease. However, bone-specific ALP, a common marker used for bone turnover, has not been required to be tested.
Conclusion
This case highlights a patient with normal total ALP, but low bone-specific ALP diagnosed with HPP confirmed by genetic testing. This case warrants future investigation into the diagnostic approach to HPP and the diagnostic utility between ALP and bone-specific ALP.
背景/目的高磷酸盐血症(HPP)是一种与血清碱性磷酸酶(ALP)活性低有关的罕见疾病。病例报告一名 36 岁的女性患者因进行性疲劳、虚弱和关节疼痛而就诊。由于这些症状,她过去曾接受过遗传性疾病的评估,结果发现她有多次总 ALP 水平在正常范围内但维生素 B6 水平升高的病史。她还报告说,童年时牙齿松动,牙龈呈 "灰色"。为怀疑 HPP,对骨特异性 ALP 进行了检测,结果为 4.4 μ/L(参考范围:5.3-19.5 μg/L),因此需要进行基因检测。基因检测证实了 ALPL 基因的阳性致病变异,即 c.542C>T(p.Ser181Leu)变异。她开始接受asfotase alfa治疗以改善症状。讨论HPP是根据临床怀疑和实验室结果确诊的,这可能导致诊断不足或误诊。目前的文献报道,低总 ALP 水平是 HPP 的主要生化指标,也是诊断该病所需的唯一水平。然而,骨特异性 ALP 是骨转换的常用标志物,却不需要进行检测。结论本病例重点介绍了一名总 ALP 正常但骨特异性 ALP 偏低的患者,经基因检测确诊为 HPP。本病例值得今后研究 HPP 的诊断方法以及 ALP 和骨特异性 ALP 之间的诊断效用。